Neonatal herpes: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Neonatal herpes | |||
| image = [[File:Herpes_néonatal_Herpes_simplex_b.jpg|250px]] | |||
| caption = Neonatal herpes simplex virus infection | |||
| field = [[Pediatrics]], [[Infectious disease]] | |||
| symptoms = [[Skin lesions]], [[fever]], [[lethargy]], [[seizures]] | |||
| complications = [[Encephalitis]], [[disseminated infection]], [[death]] | |||
| onset = [[Neonatal period]] | |||
| duration = Varies | |||
| causes = [[Herpes simplex virus]] (HSV-1, HSV-2) | |||
| risks = [[Maternal herpes infection]], [[premature birth]] | |||
| diagnosis = [[Polymerase chain reaction|PCR]], [[viral culture]], [[serology]] | |||
| differential = [[Bacterial meningitis]], [[sepsis]], [[congenital infections]] | |||
| prevention = [[Cesarean section]], [[antiviral prophylaxis]] | |||
| treatment = [[Antiviral drugs]] (e.g., [[acyclovir]]) | |||
| prognosis = Varies; can be severe | |||
| frequency = 1 in 3,200 to 1 in 10,000 live births | |||
}} | |||
== '''Alternate names''' == | == '''Alternate names''' == | ||
Neonatal herpes simplex virus infection; Neonatal HSV infection | Neonatal herpes simplex virus infection; Neonatal HSV infection | ||
== '''Summary''' == | == '''Summary''' == | ||
Herpes simplex virus (HSV) infection in newborn infants can present with the following manifestations: | Herpes simplex virus (HSV) infection in newborn infants can present with the following manifestations: | ||
* Disseminated disease involving multiple organs, most prominently liver and lungs (25%) | * Disseminated disease involving multiple organs, most prominently liver and lungs (25%) | ||
* Localized central nervous system (CNS) disease, with or without skin involvement (30%) | * Localized central nervous system (CNS) disease, with or without skin involvement (30%) | ||
* Disease limited to the skin, eyes, and/or mouth (SEM disease) (45%) | * Disease limited to the skin, eyes, and/or mouth (SEM disease) (45%) | ||
<youtube> | <youtube> | ||
title='''{{PAGENAME}}''' | title='''{{PAGENAME}}''' | ||
| Line 17: | Line 34: | ||
height=600 | height=600 | ||
</youtube> | </youtube> | ||
== '''Epidemiology''' == | == '''Epidemiology''' == | ||
The incidence of neonatal HSV infection is estimated to range between 1 in 3000 to 1 in 20,000 live births. | The incidence of neonatal HSV infection is estimated to range between 1 in 3000 to 1 in 20,000 live births. | ||
== '''Cause''' == | == '''Cause''' == | ||
* Two distinct HSV types exist: HSV-1 and HSV-2. | * Two distinct HSV types exist: HSV-1 and HSV-2. | ||
* However, either type of virus can be found in either area, and both HSV-1 and HSV-2 cause herpes disease in neonates. | * However, either type of virus can be found in either area, and both HSV-1 and HSV-2 cause herpes disease in neonates. | ||
* As with all human herpesviruses, HSV-1 and HSV-2 establish [[latency]] following primary infection, with periodic reactivation to cause recurrent symptomatic disease or asymptomatic viral shedding. | * As with all human herpesviruses, HSV-1 and HSV-2 establish [[latency]] following primary infection, with periodic reactivation to cause recurrent symptomatic disease or asymptomatic viral shedding. | ||
[[File:Herpes néonatal Herpes simplex a.jpg | [[File:Herpes néonatal Herpes simplex a.jpg|left|thumb]] | ||
== '''Transmission''' == | == '''Transmission''' == | ||
* HSV is transmitted to a neonate most commonly during birth through an infected maternal genital tract but can be caused by an ascending infection through ruptured or intact amniotic membranes. | * HSV is transmitted to a neonate most commonly during birth through an infected maternal genital tract but can be caused by an ascending infection through ruptured or intact amniotic membranes. | ||
* Other less common sources of neonatal infection include postnatal transmission from a parent or other caregiver, most often from a non-genital lesion, for example on the mouth or hands. | * Other less common sources of neonatal infection include postnatal transmission from a parent or other caregiver, most often from a non-genital lesion, for example on the mouth or hands. | ||
== '''Signs and symptoms''' == | == '''Signs and symptoms''' == | ||
Signs and symptoms may include: | Signs and symptoms may include: | ||
* Mucocutaneous [[vesicles]] | * Mucocutaneous [[vesicles]] | ||
* [[Sepsis]]-like illness (fever or [[hypothermia]], irritability, lethargy, respiratory distress, [[apnea]], abdominal [[distension]], [[hepatomegaly]], [[ascites]]) | * [[Sepsis]]-like illness (fever or [[hypothermia]], irritability, lethargy, respiratory distress, [[apnea]], abdominal [[distension]], [[hepatomegaly]], [[ascites]]) | ||
* CSF [[pleocytosis]] | * CSF [[pleocytosis]] | ||
| Line 43: | Line 56: | ||
* Elevated liver transaminases, viral [[hepatitis]], or [[acute liver failure]] | * Elevated liver transaminases, viral [[hepatitis]], or [[acute liver failure]] | ||
* [[Conjunctivitis]], excessive tearing, or painful eye symptoms | * [[Conjunctivitis]], excessive tearing, or painful eye symptoms | ||
== '''Diagnosis''' == | == '''Diagnosis''' == | ||
To diagnose neonatal HSV infection, the following specimens should be obtained: | To diagnose neonatal HSV infection, the following specimens should be obtained: | ||
* Swab specimens from the mouth, nasopharynx, conjunctivae, and anus ( | * Swab specimens from the mouth, nasopharynx, conjunctivae, and anus (“surface cultures”) for HSV culture and, if desired, for HSV PCR assay; | ||
* Specimens of skin vesicles for HSV culture and, if desired, for [[PCR]] assay | * Specimens of skin vesicles for HSV culture and, if desired, for [[PCR]] assay | ||
* CSF sample for HSV PCR assay | * CSF sample for HSV PCR assay | ||
* Whole blood sample for HSV PCR assay and | * Whole blood sample for HSV PCR assay and | ||
* Whole blood sample for measuring alanine aminotransferase (ALT). | * Whole blood sample for measuring alanine aminotransferase (ALT). | ||
Positive cultures obtained from any of the surface sites more than 12 to 24 hours after birth indicate viral replication and are, therefore, suggestive of infant infection rather than merely contamination after intrapartum exposure. | Positive cultures obtained from any of the surface sites more than 12 to 24 hours after birth indicate viral replication and are, therefore, suggestive of infant infection rather than merely contamination after intrapartum exposure. | ||
== '''Treatment''' == | == '''Treatment''' == | ||
* Parenteral [[acyclovir]] is the treatment for neonatal HSV infections. | * Parenteral [[acyclovir]] is the treatment for neonatal HSV infections. | ||
* Parenteral acyclovir should be administered to all neonates with HSV disease, regardless of manifestations and clinical findings. | * Parenteral acyclovir should be administered to all neonates with HSV disease, regardless of manifestations and clinical findings. | ||
{{Viral diseases}} | {{Viral diseases}} | ||
Latest revision as of 05:58, 8 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Neonatal herpes | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Skin lesions, fever, lethargy, seizures |
| Complications | Encephalitis, disseminated infection, death |
| Onset | Neonatal period |
| Duration | Varies |
| Types | N/A |
| Causes | Herpes simplex virus (HSV-1, HSV-2) |
| Risks | Maternal herpes infection, premature birth |
| Diagnosis | PCR, viral culture, serology |
| Differential diagnosis | Bacterial meningitis, sepsis, congenital infections |
| Prevention | Cesarean section, antiviral prophylaxis |
| Treatment | Antiviral drugs (e.g., acyclovir) |
| Medication | N/A |
| Prognosis | Varies; can be severe |
| Frequency | 1 in 3,200 to 1 in 10,000 live births |
| Deaths | N/A |
Alternate names[edit]
Neonatal herpes simplex virus infection; Neonatal HSV infection
Summary[edit]
Herpes simplex virus (HSV) infection in newborn infants can present with the following manifestations:
- Disseminated disease involving multiple organs, most prominently liver and lungs (25%)
- Localized central nervous system (CNS) disease, with or without skin involvement (30%)
- Disease limited to the skin, eyes, and/or mouth (SEM disease) (45%)
Epidemiology[edit]
The incidence of neonatal HSV infection is estimated to range between 1 in 3000 to 1 in 20,000 live births.
Cause[edit]
- Two distinct HSV types exist: HSV-1 and HSV-2.
- However, either type of virus can be found in either area, and both HSV-1 and HSV-2 cause herpes disease in neonates.
- As with all human herpesviruses, HSV-1 and HSV-2 establish latency following primary infection, with periodic reactivation to cause recurrent symptomatic disease or asymptomatic viral shedding.

Transmission[edit]
- HSV is transmitted to a neonate most commonly during birth through an infected maternal genital tract but can be caused by an ascending infection through ruptured or intact amniotic membranes.
- Other less common sources of neonatal infection include postnatal transmission from a parent or other caregiver, most often from a non-genital lesion, for example on the mouth or hands.
Signs and symptoms[edit]
Signs and symptoms may include:
- Mucocutaneous vesicles
- Sepsis-like illness (fever or hypothermia, irritability, lethargy, respiratory distress, apnea, abdominal distension, hepatomegaly, ascites)
- CSF pleocytosis
- Seizures
- Focal neurologic signs
- Abnormal neuroimaging
- Respiratory distress, apnea, or progressive pneumonitis
- Thrombocytopenia
- Elevated liver transaminases, viral hepatitis, or acute liver failure
- Conjunctivitis, excessive tearing, or painful eye symptoms
Diagnosis[edit]
To diagnose neonatal HSV infection, the following specimens should be obtained:
- Swab specimens from the mouth, nasopharynx, conjunctivae, and anus (“surface cultures”) for HSV culture and, if desired, for HSV PCR assay;
- Specimens of skin vesicles for HSV culture and, if desired, for PCR assay
- CSF sample for HSV PCR assay
- Whole blood sample for HSV PCR assay and
- Whole blood sample for measuring alanine aminotransferase (ALT).
Positive cultures obtained from any of the surface sites more than 12 to 24 hours after birth indicate viral replication and are, therefore, suggestive of infant infection rather than merely contamination after intrapartum exposure.
Treatment[edit]
- Parenteral acyclovir is the treatment for neonatal HSV infections.
- Parenteral acyclovir should be administered to all neonates with HSV disease, regardless of manifestations and clinical findings.
| Infectious diseases – viral systemic diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Conditions originating in the perinatal period / fetal disease | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Vertically transmitted infections | ||||||||
|---|---|---|---|---|---|---|---|---|
|
NIH genetic and rare disease info[edit]
Neonatal herpes is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Neonatal herpes
|


